相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
Brian A. Walker et al.
BLOOD (2011)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
Neha Korde et al.
BLOOD (2011)
Comparison of Immunofixation, Serum Free Light Chain, and Immunophenotyping for Response Evaluation and Prognostication in Multiple Myeloma
Bruno Paiva et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients
Annemiek Broyl et al.
BLOOD (2010)
CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
Robert F. Luo et al.
HUMAN PATHOLOGY (2010)
CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency
Menno C. van Zelm et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
Maria-Victoria Mateos et al.
LANCET ONCOLOGY (2010)
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling
N. C. Gutierrez et al.
LEUKEMIA (2010)
Prognostic Significance of Copy-Number Alterations in Multiple Myeloma
Herve Avet-Loiseau et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
R. A. Kyle et al.
LEUKEMIA (2009)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
Prognostic value of immunophenotyping in multiple myeloma:: A study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy
Gema Mateo et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
Ernesto Perez-Persona et al.
BLOOD (2007)
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma
Robert A. Kyle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
CD28-mediated regulation of multiple myeloma cell proliferation and survival
Nizar J. Bahlis et al.
BLOOD (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
John D. Shaughnessy et al.
BLOOD (2007)
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
N. C. Gutierrez et al.
LEUKEMIA (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Building of the tetraspanin web: Distinct structural domains of CD81 function in different cellular compartments
T Shoham et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Aberrant expression of tetraspanin molecules in B-cell chronic lymphoproliferative disorders and its correlation with normal B-cell maturation
S Barrena et al.
LEUKEMIA (2005)
International staging system for multiple myeloma
PR Greipp et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Genetic abnormalities and patterns of antigenic expression in multiple myeloma
G Mateo et al.
CLINICAL CANCER RESEARCH (2005)
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia
R Schroers et al.
LEUKEMIA (2005)
Bortezomib is an efficient agent in plasma cell leukemias
A Esparís-Ogando et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells
V Carloni et al.
ONCOGENE (2004)
B cell signaling is regulated by induced palmitoylation of CD81
A Cherukuri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts
A Cherukuri et al.
JOURNAL OF IMMUNOLOGY (2004)
Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma
NC Gutiérrez et al.
BLOOD (2004)
The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment
T Shoham et al.
JOURNAL OF IMMUNOLOGY (2003)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
M Crespo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
